Review
doi: 10.1093/eurheartj/ehq079.
Epub 2010 Mar 23.
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
Affiliations
- PMID: 20332181
- DOI: 10.1093/eurheartj/ehq079
Item in Clipboard
Review
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
Eur Heart J.
2010 May.
Abstract
Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter ablation is increasingly being used to treat patients with AF, and recent studies have reported success rates >80% for paroxysmal AF and >70% for persistent AF. The purpose of this work is to review the evidence supporting catheter ablation and compare it with pharmacological treatment in the management of AF.
Similar articles
-
Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.Expert Rev Cardiovasc Ther. 2009 Mar;7(3):311-22. doi: 10.1586/14779072.7.3.311. Expert Rev Cardiovasc Ther. 2009. PMID: 19296769 Review.
-
A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study).Europace. 2007 Mar;9(3):182-5. doi: 10.1093/europace/eum004. Epub 2007 Feb 15. Europace. 2007. PMID: 17303627 Clinical Trial.
-
Management of atrial fibrillation in patients with heart failure.J Card Fail. 2008 Apr;14(3):232-7. doi: 10.1016/j.cardfail.2007.10.023. J Card Fail. 2008. PMID: 18381187 Review.
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.Can J Cardiol. 2011 Jan-Feb;27(1):60-6. doi: 10.1016/j.cjca.2010.11.011. Can J Cardiol. 2011. PMID: 21329863
-
Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation.Expert Rev Cardiovasc Ther. 2007 Jul;5(4):663-72. doi: 10.1586/14779072.5.4.663. Expert Rev Cardiovasc Ther. 2007. PMID: 17605645 Review.
Cited by
-
Ablative Management of Persistent Atrial Fibrillation (PeAF) with Posterior Wall Isolation (PWI): Where Do We Stand?J Cardiovasc Dev Dis. 2023 Jun 27;10(7):273. doi: 10.3390/jcdd10070273. J Cardiovasc Dev Dis. 2023. PMID: 37504529 Free PMC article.
-
Cardioversion versus ablation versus 'pace and ablate' for persistent atrial fibrillation in older patients.Br J Cardiol. 2024 Apr 16;31(2):014. doi: 10.5837/bjc.2024.014. eCollection 2024. Br J Cardiol. 2024. PMID: 39555469 Free PMC article.
-
Monitoring of irrigated lesion formation with single fiber based multispectral system using machine learning.J Biophotonics. 2022 Sep;15(9):e202100374. doi: 10.1002/jbio.202100374. Epub 2022 Jun 15. J Biophotonics. 2022. PMID: 35666015 Free PMC article.
-
Costs and clinical consequences of suboptimal atrial fibrillation management.Clinicoecon Outcomes Res. 2012;4:79-90. doi: 10.2147/CEOR.S30090. Epub 2012 Mar 26. Clinicoecon Outcomes Res. 2012. PMID: 22500125 Free PMC article.
-
Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation.Clin Res Cardiol. 2013 Apr;102(4):315-8. doi: 10.1007/s00392-012-0529-y. Epub 2012 Dec 14. Clin Res Cardiol. 2013. PMID: 23239408 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
